← Dashboard
Stock
TU
TELUS CORPLatest close $134 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
4
27 funds tracked
Ever held
6
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Aug 13, 2013Nov 9, 2016May 12, 2023May 15, 2025
Now
4
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $15 | $13 | -14% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $15 | $13 | -14% |
| Millennium Management re-entered | Q3 2024(8Q snapshot) | 7Q | $15 | $13 | -14% |
| Two Sigma Investments | Q2 2025(8Q snapshot) | 4Q | $15 | $13 | -17% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates 7× in & out | Q2 2023 | Q2 2025 | → $15 | -14% |
| Maverick Capital | Q2 2023 | Q3 2023 | → $15 | -13% |
Fundamentals
XBRL · TELUS CORPNot enough XBRL history to plot. TELUS CORPhasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for TELUS CORP — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KFORM 6-KMay 11, 2026
- 6-KFORM 6-KMay 8, 2026
- 6-KFORM 6-KMay 8, 2026
- 6-KFORM 6-KMay 8, 2026
- 6-KFORM 6-KApr 2, 2026
- 6-KFORM 6-KApr 2, 2026
- 6-KFORM 6-KMar 9, 2026
- 6-KFORM 6-KFeb 25, 2026
- 6-KFORM 6-KFeb 13, 2026
- 6-KFORM 6-KFeb 12, 2026
- 6-KFORM 6-KFeb 12, 2026
- 6-KFORM 6-KFeb 12, 2026
- 6-KFORM 6-KFeb 12, 2026
- 6-KFORM 6-KFeb 12, 2026
- 6-KFORM 6-KJan 8, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q2 2025 | open | $15 | $12 | -18% |
| Millennium Management | Q2 2025 | open | $15 | $12 | -18% |
| Citadel Advisors | Q3 2024 | open | $15 | $12 | -16% |
| D.E. Shaw | Q3 2024 | open | $15 | $12 | -16% |
| Millennium Management | Q3 2024 | Q4 2024 | $15 | $14 | -3% |
| Maverick Capital | Q2 2023 | Q3 2023 | $17 | $15 | -13% |
| Bridgewater Associates | Q2 2023 | Q2 2025 | $17 | $15 | -14% |
| Bridgewater Associates | Q1 2021 | Q1 2022 | $16 | $20 | +24% |
| Bridgewater Associates | Q3 2017 | Q3 2020 | $12 | $14 | +18% |
| Bridgewater Associates | Q4 2016 | Q1 2017 | $9.97 | $10 | +5% |
| Bridgewater Associates | Q3 2015 | Q2 2016 | $9.93 | $9.60 | -3% |
| Bridgewater Associates | Q1 2015 | Q2 2015 | $10 | $10 | +1% |
| Bridgewater Associates | Q3 2013 | Q2 2014 | $8.30 | $10 | +26% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.